季节性流感疫苗在瘤微环境中差异激活和调节类似收费的受体表达
Kajal H Gupta1,2, Eileena F Giurini1, Andrew Zloza3,4
1Division of Surgical Oncology, Department of Surgery, Rush University Medical Center, Chicago, IL, United States.
Frontiers in oncology
|March 13, 2024
概括
没有辅助剂的流感疫苗通过托尔样受体7 (TLR7) 激活来降低瘤生长. 辅助疫苗刺激不同的TLR,影响抗瘤免疫力和疫苗反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 疫苗学 疫苗学 疫苗学
背景情况:
- 收费类受体 (TLRs) 在癌症发育和抗瘤免疫中起着双重作用.
- TLRs参与了对流感病毒感染的天生的免疫反应.
- 之前的研究表明,未添加辅助剂的流感疫苗调节TLR7,诱导黑色素瘤的抗瘤反应.
研究的目的:
- 通过未添加剂的流感疫苗研究TLRs对瘤生长减少的贡献.
- 确定非辅助型与辅助型流感疫苗对TLR刺激的差异.
- 阐明TLR7在未添加辅助剂的疫苗抗瘤作用中的作用.
主要方法:
- 在小鼠黑色素瘤模型中,内注射未添加剂和添加剂的流感疫苗.
- 评估了对免疫细胞的TLR表达和激活.
- 利用TLR7缺乏的小鼠来评估TLR7在瘤反应中的作用.
主要成果:
- 没有辅助的疫苗刺激了TLR3和TLR7;辅助的疫苗刺激了TLR4和TLR9.
- 在TLR7缺乏的小鼠中,减少瘤生长和改善未添加剂疫苗的存活率有所减少.
- 这两种疫苗都调节了TLR表达在先天性和适应性免疫细胞上.
结论:
- 对于未添加辅助剂的流感疫苗的抗瘤疗效来说,TLR7是至关重要的.
- 疫苗配方的差异性TLR刺激会影响抗瘤免疫反应.
- 这些发现增强了对疫苗介导瘤结果的机制性理解.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Vaccinations
44.5K
Overview
44.5K


